---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-24-000160"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:49:37.362113+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Viemed Q2 2024 revenue hits record $55.0M, up 27% YoY; Adjusted EBITDA up 31%

## Summary
- Net revenues $55.0M (record), up 27% YoY and 9% sequential from Q1 2024.
- Net income $1.5M for Q2 2024.
- Adjusted EBITDA $12.8M, a 31% increase over Q2 2023.
- Company reports strong growth in respiratory care and home medical equipment services.

## SEC filing metadata
- accession: 0001729149-24-000160
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914924000160/0001729149-24-000160-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914924000160/vmd-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-24-000160
- JSON: https://secwatch.observer/filing/0001729149-24-000160.json
- Plain text: https://secwatch.observer/filing/0001729149-24-000160.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.